BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14656993)

  • 1. Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation.
    Catalano A; Caprari P; Rodilossi S; Betta P; Castellucci M; Casazza A; Tamagnone L; Procopio A
    FASEB J; 2004 Feb; 18(2):358-60. PubMed ID: 14656993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
    Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling.
    Markel TA; Crisostomo PR; Wang M; Herring CM; Lahm T; Meldrum KK; Lillemoe KD; Rescorla FJ; Meldrum DR
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G958-63. PubMed ID: 17204543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ; Smith MF; Goldberg JB
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells.
    Yashima R; Abe M; Tanaka K; Ueno H; Shitara K; Takenoshita S; Sato Y
    J Cell Physiol; 2001 Aug; 188(2):201-10. PubMed ID: 11424087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
    Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
    Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.
    Rousseau S; Houle F; Landry J; Huot J
    Oncogene; 1997 Oct; 15(18):2169-77. PubMed ID: 9393975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous production of nitric oxide by vascular endothelial growth factor down-regulates proliferation of choriocarcinoma cells.
    Cha MS; Lee MJ; Je GH; Kwak JY
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1061-6. PubMed ID: 11352660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential MAP kinases activation during semaphorin3A-induced repulsion or apoptosis of neural progenitor cells.
    Bagnard D; Sainturet N; Meyronet D; Perraut M; Miehe M; Roussel G; Aunis D; Belin MF; Thomasset N
    Mol Cell Neurosci; 2004 Apr; 25(4):722-31. PubMed ID: 15080899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
    Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
    Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
    Lamalice L; Houle F; Jourdan G; Huot J
    Oncogene; 2004 Jan; 23(2):434-45. PubMed ID: 14724572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.
    Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM
    Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion.
    Karihaloo A; Karumanchi SA; Cantley WL; Venkatesha S; Cantley LG; Kale S
    Mol Cell Biol; 2005 Sep; 25(17):7441-8. PubMed ID: 16107693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
    Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
    FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor.
    Yu Y; Sato JD
    J Cell Physiol; 1999 Feb; 178(2):235-46. PubMed ID: 10048588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial heat shock protein-60 increases epithelial cell proliferation through the ERK1/2 MAP kinases.
    Zhang L; Pelech SL; Mayrand D; Grenier D; Heino J; Uitto VJ
    Exp Cell Res; 2001 May; 266(1):11-20. PubMed ID: 11339820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; IƱiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.